The AACR-Mirati Cancer Chemical Biology Research Fellowship represents a joint effort to encourage and support postdoctoral or clinical research fellow to conduct chemical biology research directed at developing novel approaches to targeting the difficult-to-drug cancer drivers and to establish a successful career path in this field. The research proposed for funding should be basic or translational in nature.
This fellowship provides two-year grants of $120,000 to support the salary and benefits of the fellow while working on mentored chemical biology research. A partial amount of funds may be designated for non-personnel expenses, such as research/laboratory supplies, equipment, publication charges for manuscripts that pertain directly to the funded project, and other research expenses.
Deadline: Jan. 27, 2022
At the start of the grant term on July 1, 2022, applicants must:
- Hold a mentored research position with the title of postdoctoral fellow, clinical research fellow, or the equivalent
- If eligibility is based on a future position, the position must be confirmed at the time of application, and CANNOT be contingent upon receiving this grant.
- If the future position is at a different institution than the applicant’s current institution, the applicant must contact the AACR’s Scientific Review and Grants Administration Department (AACR’s SRGA) at grants@aacr.org before submitting their application for information on additional verification materials/signatures that may be required.
- Have completed their most recent doctoral degree within the past five years (i.e., degree cannot have been conferred before July 1, 2017; the formal date of receipt of doctoral degree is the date the degree was conferred, as indicated on their diploma and/or transcript)Applicants with a medical degree must have completed their most recent doctoral degree or medical residency - whichever date is later - within the past five years.
- Work under the auspices of a mentor at an academic, medical, or research institution anywhere in the world.